We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Cutting-Edge Imaging Pinpoints Where and When Hemorrhagic Stroke Has Occurred

By HospiMedica International staff writers
Posted on 13 Jun 2022

Hemorrhagic stroke, where a weakened vessel in the brain ruptures, can lead to permanent disability or death. More...

Across the globe, over 15 million people are coping with its effects. Time is of the essence when it comes to stroke; the sooner doctors can start treatment, the better the odds they can limit damage. Now, a new study has moved us one step closer to identifying when the bleeding associated with a hemorrhagic stroke starts - critical information for improving patient outcomes.

Using the Mid-IR beamline at the Canadian Light Source (CLS) at the University of Saskatchewan (USask, Saskatoon, Canada), the research team examined brain tissue samples with a special technique called Fourier-transform infrared imaging. The novel approach enabled the researchers to identify changes in the brain specific to hemorrhagic stroke. According to the researchers, the combination of the beamline and infrared imaging made it easy to detect markers of brain damage caused by hemorrhagic stroke.

With synchrotron technology, the team could see where a bleed originated and the extent of oxidative damage it caused – something impossible to do with a microscope or traditional approaches to imaging. Armed with this new approach, and a better understanding of what they are looking for, the researchers will now go back through their extensive “library” of stroke tissue samples to gain a clearer picture of the speed at which oxidative damage begins to ramp up. The team’s findings could eventually enable doctors to use clinical imaging – such as MRI or CT scans – to pinpoint where, and how long ago, a hemorrhagic stroke occurred in the brain. Knowing when bleeding has started can provide clinicians with a clearer picture of the time window they have to act.

“In a sense, this is giving us ‘superhuman vision’ to look at these brains and map out what’s happening metabolically,” said Dr. Jake Pushie, a member of the research team at USask’s College of Medicine.

“Being able to understand what is going on biologically, when we see any kinds of changes in the clinical images, could help doctors provide better care when it comes to minimizing the tissue damage associated with stroke,” added Miranda Messmer, another member of the research team.

Related Links:
University of Saskatchewan


Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Captivator EMR Device
Captivator Endoscopic Mucosal Resection Device
New
Pocket Fetal Doppler
CONTEC10C/CL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.